136 related articles for article (PubMed ID: 9590694)
1. Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells.
Qiu Y; Ravi L; Kung HJ
Nature; 1998 May; 393(6680):83-5. PubMed ID: 9590694
[TBL] [Abstract][Full Text] [Related]
2. ErbB kinases and NDF signaling in human prostate cancer cells.
Grasso AW; Wen D; Miller CM; Rhim JS; Pretlow TG; Kung HJ
Oncogene; 1997 Nov; 15(22):2705-16. PubMed ID: 9400997
[TBL] [Abstract][Full Text] [Related]
3. Expression of the activated p185erbB2 tyrosine kinase in human epithelial cells leads to MAP kinase activation but does not confer oncogenicity.
Nowak F; Jacquemin-Sablon A; Pierre J
Exp Cell Res; 1997 Mar; 231(2):251-9. PubMed ID: 9087165
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-6 induces tyrosine phosphorylation of the Ras activating protein Shc, and its complex formation with Grb2 in the human multiple myeloma cell line LP-1.
Neumann C; Zehentmaier G; Danhauser-Riedl S; Emmerich B; Hallek M
Eur J Immunol; 1996 Feb; 26(2):379-84. PubMed ID: 8617307
[TBL] [Abstract][Full Text] [Related]
5. IL-6 triggers cell growth via the Ras-dependent mitogen-activated protein kinase cascade.
Ogata A; Chauhan D; Teoh G; Treon SP; Urashima M; Schlossman RL; Anderson KC
J Immunol; 1997 Sep; 159(5):2212-21. PubMed ID: 9278309
[TBL] [Abstract][Full Text] [Related]
6. Sustained mitogen-activated protein kinase activation is induced by transforming erbB receptor complexes.
Wu CJ; Qian X; O'Rourke DM
DNA Cell Biol; 1999 Oct; 18(10):731-41. PubMed ID: 10541432
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of ErbB2 receptor inhibits IGF-I-induced Shc-MAPK signaling pathway in breast cancer cells.
Lu Y; Zi X; Zhao Y; Pollak M
Biochem Biophys Res Commun; 2004 Jan; 313(3):709-15. PubMed ID: 14697248
[TBL] [Abstract][Full Text] [Related]
8. UV activation of receptor tyrosine kinase activity.
Coffer PJ; Burgering BM; Peppelenbosch MP; Bos JL; Kruijer W
Oncogene; 1995 Aug; 11(3):561-9. PubMed ID: 7543196
[TBL] [Abstract][Full Text] [Related]
9. Shc mediates IL-6 signaling by interacting with gp130 and Jak2 kinase.
Giordano V; De Falco G; Chiari R; Quinto I; Pelicci PG; Bartholomew L; Delmastro P; Gadina M; Scala G
J Immunol; 1997 May; 158(9):4097-103. PubMed ID: 9126968
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor and betacellulin mediate signal transduction through co-expressed ErbB2 and ErbB3 receptors.
Alimandi M; Wang LM; Bottaro D; Lee CC; Kuo A; Frankel M; Fedi P; Tang C; Lippman M; Pierce JH
EMBO J; 1997 Sep; 16(18):5608-17. PubMed ID: 9312020
[TBL] [Abstract][Full Text] [Related]
11. Lipid rafts and the local density of ErbB proteins influence the biological role of homo- and heteroassociations of ErbB2.
Nagy P; Vereb G; Sebestyén Z; Horváth G; Lockett SJ; Damjanovich S; Park JW; Jovin TM; Szöllosi J
J Cell Sci; 2002 Nov; 115(Pt 22):4251-62. PubMed ID: 12376557
[TBL] [Abstract][Full Text] [Related]
12. Opposite effects of the p52shc/p46shc and p66shc splicing isoforms on the EGF receptor-MAP kinase-fos signalling pathway.
Migliaccio E; Mele S; Salcini AE; Pelicci G; Lai KM; Superti-Furga G; Pawson T; Di Fiore PP; Lanfrancone L; Pelicci PG
EMBO J; 1997 Feb; 16(4):706-16. PubMed ID: 9049300
[TBL] [Abstract][Full Text] [Related]
13. The Src homology 2 domain protein Shb transmits basic fibroblast growth factor- and nerve growth factor-dependent differentiation signals in PC12 cells.
Karlsson T; Kullander K; Welsh M
Cell Growth Differ; 1998 Sep; 9(9):757-66. PubMed ID: 9751119
[TBL] [Abstract][Full Text] [Related]
14. Involvement of Janus kinases, p52shc, Raf-1, and MEK-1 in the IL-6-induced mitogen-activated protein kinase cascade of a growth-responsive B cell line.
Kumar G; Gupta S; Wang S; Nel AE
J Immunol; 1994 Nov; 153(10):4436-47. PubMed ID: 7963520
[TBL] [Abstract][Full Text] [Related]
15. Heregulin-stimulated acetylcholine receptor gene expression in muscle: requirement for MAP kinase and evidence for a parallel inhibitory pathway independent of electrical activity.
Altiok N; Altiok S; Changeux JP
EMBO J; 1997 Feb; 16(4):717-25. PubMed ID: 9049301
[TBL] [Abstract][Full Text] [Related]
16. Expression of the ErbB4 receptor causes reversal regulation of PP2A in the Shc signal transduction pathway in human cancer cells.
Yumoto N; Yu X; Hatakeyama M
Mol Cell Biochem; 2006 Apr; 285(1-2):165-71. PubMed ID: 16477370
[TBL] [Abstract][Full Text] [Related]
17. Nerve growth factor induced stimulation of Ras requires Trk interaction with Shc but does not involve phosphoinositide 3-OH kinase.
Hallberg B; Ashcroft M; Loeb DM; Kaplan DR; Downward J
Oncogene; 1998 Aug; 17(6):691-7. PubMed ID: 9715270
[TBL] [Abstract][Full Text] [Related]
18. The protein product of the c-cbl oncogene rapidly complexes with the EGF receptor and is tyrosine phosphorylated following EGF stimulation.
Bowtell DD; Langdon WY
Oncogene; 1995 Oct; 11(8):1561-7. PubMed ID: 7478580
[TBL] [Abstract][Full Text] [Related]
19. Shc products are substrates of erbB-2 kinase.
Segatto O; Pelicci G; Giuli S; Digiesi G; Di Fiore PP; McGlade J; Pawson T; Pelicci PG
Oncogene; 1993 Aug; 8(8):2105-12. PubMed ID: 8101647
[TBL] [Abstract][Full Text] [Related]
20. The uncoupling of Shc activation from distal intracellular signalling in a cell line which expresses a truncated human epidermal growth factor receptor.
McNeil A; Larkins R; Clark S
Biochem Biophys Res Commun; 1996 Jan; 218(3):740-4. PubMed ID: 8579583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
